SCHEMBL16369672

SCHEMBL16369672

Cc1c2cc(Br)ccc2nn1C1CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCHR1 Q99705 3/20 0.42
▸ IRAK4 Q9NWZ3 4/20 0.36
▸ CASP3 P42574 3/20 0.36
▸ HTT P42858 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ RXFP1 Q9HBX9 2/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ TNF P01375 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ MPO P05164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25335464 0.78 HRH4 (0.41) HTTMEN1POLBKMT2ACYP2D6
SCHEMBL31559800 0.78 IRAK4 (0.36) IRAK4MPO
SCHEMBL26129864 0.78 CYP4F2 (0.39) CASP3HTTPOLBKMT2ARXFP1
SCHEMBL13106339 0.74 CASP3 (0.48) MCHR1CASP3HTTMEN1KMT2A
SCHEMBL29343446 0.72 POLB (0.34) MCHR1IRAK4HTTMEN1POLB
SCHEMBL29121967 0.72 MAPT (0.36) IRAK4HTTMEN1POLBKMT2A
SCHEMBL29122457 0.72 MAPT (0.38) IRAK4HTTMEN1POLBKMT2A
SCHEMBL29123043 0.71 POLB (0.40) HTTMEN1POLBKMT2ARXFP1
SCHEMBL29122733 0.70 L3MBTL1 (0.43) CASP3HTTPOLBKMT2ACYP1A2
SCHEMBL29121823 0.70 MAPK8 (0.45) CASP3HTTPOLBKMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3019487-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2016-05-18 — — EP disclosed
US-9199963-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-12-01 — — US disclosed
WO-2015005489-A1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-01-15 — — WO disclosed
Send feedback